Insights

Gathering insights about ASLA…

Similar companies to ASLA

ASLA Tech Stack

ASLA uses 8 technology products and services including oEmbed, Frederick, Office 365, and more. Explore ASLA's tech stack below.

oEmbed
Dev Tools
Frederick
Marketing Automation
Office 365
Office Suites
Windows Server
Operating Systems
Sprout Social
Social Media Marketing Software
YouTube
Video Players
Facebook
Widgets
AddThis
Widgets

Media & News

ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
SAN MATEO, Calif. and SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN” or the “Company”), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that its Singapore-incorporated, sole operating subsidiary, ASLAN Pharmaceuticals Pte Ltd (“ASLAN SG”), has filed for voluntary liquidation. The decision follows a comprehensive review by the Board of the Company of ASLAN SG's financial position and strategic alternatives. Effective immediately, all employees of ASLAN SG and fellow subsidiary ASLAN Pharmaceuticals (USA) Inc. have been terminated.
Jul 17, 2024 | www.globenewswire.com
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal
SAN MATEO, Calif. and SINGAPORE, July 15, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN” or the “Company”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that on July 9, 2024, the Company was notified by the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that, based upon the Company's non-compliance with the $1.00 bid price and $2.5 million stockholders' equity requirements for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1), respectively, the Staff had determined to delist the Company's securities from Nasdaq. Upon consideration by the Company's board of directors, the Company has determined not to request a hearing before the Nasdaq Hearings Panel.
Jul 15, 2024 | www.globenewswire.com
All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy
ASLAN Pharmaceuticals (ASLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Jun 04, 2024 | www.zacks.com
Here's Why ASLAN Pharmaceuticals (ASLN) Could be Great Choice for a Bottom Fisher
ASLAN Pharmaceuticals (ASLN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Jun 04, 2024 | www.zacks.com
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
SAN MATEO, Calif. and SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the late-breaking poster presentation of translational data from head-to-head studies of eblasakimab and dupilumab in human healthy and COPD-derived lung tissue models at the American Thoracic Society (ATS) International Conference 2024 in San Diego, California.
May 21, 2024 | www.globenewswire.com
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
SAN MATEO, Calif. and SINGAPORE, May 09, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced financial results for the first quarter ended March 31, 2024, and provided an update on recent corporate activities.
May 09, 2024 | www.globenewswire.com
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
SAN MATEO, Calif. and SINGAPORE, May 07, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, will today host a virtual KOL event, during which Company management will present new data from the interim analysis of the Phase 2 TREK-DX study of eblasakimab in dupilumab-experienced atopic dermatitis (AD) patients. The KOL event, “Treatment Options for Atopic Dermatitis Patients with an Inadequate Response to Dupilumab: Exploring the Potential of Eblasakimab in this Sizable New Market”, will begin at 8:00 am ET and participants may register here .
May 07, 2024 | www.globenewswire.com

ASLA's Email Address Formats

ASLA uses at least 1 format(s):

ASLA Email Formats	Example	Percentage
FLast@asla.org	JDoe@asla.org	82%
First.Last@asla.org	John.Doe@asla.org	11%
FirLast@asla.org	JohDoe@asla.org	4%
Last_First@asla.org	Doe_John@asla.org	3%

Frequently Asked Questions

Where is ASLA's headquarters located?

ASLA's main headquarters is located at United States. The company has employees across 6 continents, including North AmericaAfricaEurope.

What is ASLA's phone number?

You can contact ASLA's main corporate office by phone at

+1-202-898-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ASLA's stock symbol?

ASLA is a publicly traded company; the company's stock symbol is ASLN.

What is ASLA's official website and social media links?

ASLA's official website is asla.org and has social profiles on LinkedIn.

What is ASLA's NAICS code?

ASLA's NAICS code is 23 - Construction.

How many employees does ASLA have currently?

As of February 2026, ASLA has approximately 158 employees across 6 continents, including North AmericaAfricaEurope. Key team members include Founder /Ceo: A. V.Owner: G. A.Owner: S. L.. Explore ASLA's employee directory with LeadIQ.

What industry does ASLA belong to?

ASLA operates in the Construction industry.

What technology does ASLA use?

ASLA's tech stack includes oEmbedFrederickOffice 365Windows ServerSprout SocialYouTubeFacebookAddThis.

What is ASLA's email format?

ASLA's email format typically follows the pattern of FLast@asla.org. Find more ASLA email formats with LeadIQ.

ASLA

Q: What is ASLA's official website and social media links?

ASLA's official website is asla.org. ASLA has social profiles on LinkedIn.

Q: How many employees does ASLA have currently?

ASLA has approximately 158 employees.

Q: What technology does ASLA use?

ASLA's tech stack includes React, X-XSS-Protection, D3.js, Hootsuite, jQuery.

ConstructionUnited States51-200 Employees

Learn about working at ASLA. Join LinkedIn today for free. See who you know at ASLA, leverage your professional network, and get hired.

Company Overview

Headquarters: United States
Phone number: +1-202-898-****
Website: asla.org
Stock Symbol: ASLN
NAICS Code: 23 - Construction
Employees: 51-200

Media & News

Funding & Financials

$25M$50M
ASLA's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$25M$50M
ASLA's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to ASLA

Ruppert Landscape

BrightView

NLA

U.S. Lawns

Associa

ASLA Tech Stack

Media & News

ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal

All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy

Here's Why ASLAN Pharmaceuticals (ASLN) Could be Great Choice for a Bottom Fisher

ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference

ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event

ASLA's Email Address Formats

Frequently Asked Questions

Where is ASLA's headquarters located?

What is ASLA's phone number?

What is ASLA's stock symbol?

What is ASLA's official website and social media links?

What is ASLA's NAICS code?

How many employees does ASLA have currently?

What industry does ASLA belong to?

What technology does ASLA use?

What is ASLA's email format?

ASLA

Company Overview

Media & News

ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal

All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?